EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

PharmVar GeneFocus: CYP2A6

Alec W R Langlois iD, Meghan J Chenoweth iD, David Twesigomwe iD, Giada Scantamburlo iD, Michelle Whirl-Carrillo iD, Katrin Sangkuhl iD, Teri E Klein iD, Charity Nofziger iD, Rachel F Tyndale iD, Andrea Gaedigk iD

Clinical Pharmacology & Therapeutics · 2024

DOI: 10.1002/cpt.3387 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Alec W R Langlois und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2A6. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHGRI NIH HHS, Canadian Institutes of Health Research (CIHR) Project grant, Canadian Institutes of Health Research (CIHR) Foundation grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the human CYP2A gene locus containing the highly polymorphic CYP2A6 gene. CYP2A6 plays a role in the metabolism of nicotine and various drugs. Thus, genetic variation can substantially contribute to the function of this enzyme and associated efficacy and safety. This GeneFocus provides an overview of the clinical significance of CYP2A6 , including its genetic variation and function. We also highlight and discuss caveats in the identification and characterization of allelic variation of this complex pharmacogene, a prerequisite for accurate genotype determination and prediction of phenotype status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2A6HumansPharmacogeneticsGenetic VariationPhenotypeNicotineGenotypePharmacogenomic VariantsAllelesPolymorphism, Genetic

Substanzen

Cytochrome P-450 CYP2A6CYP2A6 protein, humanNicotine

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • PharmGenetix GmbH, Niederalm, Austria.
  • Department of Biomedical Data Science, Stanford University, Stanford, California, USA.

ORCID-Profile: Alec W R Langlois, Meghan J Chenoweth, David Twesigomwe, Giada Scantamburlo, Michelle Whirl-Carrillo, Katrin Sangkuhl, Teri E Klein, Charity Nofziger, Rachel F Tyndale, Andrea Gaedigk

Förderung

  • NHGRI NIH HHS
  • Canadian Institutes of Health Research (CIHR) Project grant
  • Canadian Institutes of Health Research (CIHR) Foundation grant
  • NIH HHS
  • Sydney Brenner Charitable Trust
  • Canadian Institutes of Health Research
  • National Institutes of Health

Zitieren

APA

Langlois, A. W. R., Chenoweth, M. J., Twesigomwe, D., Scantamburlo, G., Whirl-Carrillo, M., Sangkuhl, K., Klein, T. E., Nofziger, C., Tyndale, R. F., & Gaedigk, A. (2024). PharmVar GeneFocus: CYP2A6. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3387

Vancouver

Langlois AWR, Chenoweth MJ, Twesigomwe D, Scantamburlo G, Whirl-Carrillo M, Sangkuhl K, et al. PharmVar GeneFocus: CYP2A6. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3387

BibTeX
@article{Langlois2024,
  author = {Langlois, Alec W R and Chenoweth, Meghan J and Twesigomwe, David and Scantamburlo, Giada and Whirl-Carrillo, Michelle and Sangkuhl, Katrin and Klein, Teri E and Nofziger, Charity and Tyndale, Rachel F and Gaedigk, Andrea},
  title = {PharmVar GeneFocus: CYP2A6},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1002/cpt.3387}
}
Kostenlos starten →